In addition, the analysis of the GSE109211 dataset revealed a consistent upregulation of USP18 in tumor tissue samples obtained from HCC patients who exhibited a non-responsive phenotype towards sorafenib treatment (Fig. 1E). This evidence concerns the gene USP18 and hepatocellular carcinoma.